SCHEMBL3786673

SCHEMBL3786673

CC(=O)SOc1cccc(N)c1-c1ccc(N)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.32
BRD4 O60885 1/20 0.32
TNKS O95271 1/20 0.32
PARP1 P09874 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
ACHE P22303 1/20 0.31
ALDH1A1 P00352 3/20 0.31
LMNA P02545 2/20 0.31
HSD17B10 Q99714 2/20 0.31
ADRA2B P18089 1/20 0.31
PTGS1 P23219 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789887 0.91 MAPT (0.38) BRD4ALDH1A1LMNAHSD17B10ADRA2B
SCHEMBL3783777 0.85 SMN1; SMN2 (0.41) BRD4ALDH1A1LMNANPC1MAPT
SCHEMBL3783966 0.82 ADORA2A (0.38) BRD4ALDH1A1LMNAHSD17B10ADRA2B
SCHEMBL3787196 0.81 MAPK1 (0.41) ACHEALDH1A1LMNAHSD17B10PTGS1
SCHEMBL3794457 0.80 NCOA1 (0.38) TNKSPARP1TNKS2ALDH1A1LMNA
SCHEMBL3785148 0.78 NCOA1 (0.46) ALDH1A1LMNAHSD17B10TDP1SMN1; SMN2
SCHEMBL3789085 0.76 KDR (0.35) BRD4PARP1ACHEALDH1A1LMNA
SCHEMBL3785707 0.75 ALDH1A1 (0.52) TNKSPARP1TNKS2ALDH1A1LMNA
SCHEMBL3785015 0.75 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10TDP1MEN1
SCHEMBL3788022 0.75 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MTOR 2758/4885BRD4 96/4885TNKS 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.